Skip to main content
editorial
. 2023 Oct 18;16:9–16. doi: 10.1016/j.xjon.2023.10.016

Figure 1.

Figure 1

Oncoprint comparing nonmetastatic (NM) and ever-metastatic (EM) primary lung adenocarcinoma tumors. The oncoprint displays clinical features and genes altered at significantly different frequencies between primary lung adenocarcinomas that metastasized (EM) and those that did not (NM). Hx, History; pStage, pathologic stage. (From Lengel and colleagues.12 Reprinted with permission).